These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31045797)

  • 21. Epidemiology of hepatitis B virus infection among recyclable waste collectors in central Brazil.
    Marinho TA; Lopes CL; Teles SA; Matos MA; Matos MA; Kozlowski AG; Oliveira MP; Silva ÁM; Martins RM
    Rev Soc Bras Med Trop; 2014; 47(1):18-23. PubMed ID: 24603732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
    Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
    J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status.
    Jose-Abrego A; Panduro A; Fierro NA; Roman S
    J Med Virol; 2017 Dec; 89(12):2149-2157. PubMed ID: 28792071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire.
    Navarro N; Lim N; Kim J; Joo E; Che K; Runyon BA; Mendler MH
    BMC Infect Dis; 2014 May; 14():269. PubMed ID: 24884673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil.
    Bertolini DA; Pinho JR; Saraceni CP; Moreira RC; Granato CF; Carrilho FJ
    Braz J Med Biol Res; 2006 Aug; 39(8):1083-90. PubMed ID: 16906283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
    Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
    BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening.
    Ozkan S; Atak A; Bozdayi G; Turkcuoglu S; Maral I
    Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):782-6. PubMed ID: 20889180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of hepatitis B and C viral infections in Ladakh region.
    Khan MA; Zargar SA; Upadhyay J; Lone TA; Aggarwal R; Bashir G; Ali M; Rabyang S; Namgyal T; Wani ZA
    Indian J Gastroenterol; 2018 Nov; 37(6):504-510. PubMed ID: 30543047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for hepatitis B infection in rural Vietnam.
    Duong TH; Nguyen PH; Henley K; Peters M
    Asian Pac J Cancer Prev; 2009; 10(1):97-102. PubMed ID: 19469633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.